- Report
- April 2026
- 135 Pages
Global
From €3708EUR$3,999USD£3,101GBP
- Report
- May 2026
- 185 Pages
Global
From €4172EUR$4,500USD£3,490GBP
- Report
- February 2026
- 250 Pages
Global
From €4163EUR$4,490USD£3,482GBP
- Report
- September 2026
- 188 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- September 2026
- 196 Pages
Global
From €3287EUR$3,545USD£2,749GBP
€3652EUR$3,939USD£3,055GBP
- Report
- November 2026
- 291 Pages
Global
From €5424EUR$5,850USD£4,537GBP
- Report
- July 2026
- 120 Pages
Global
From €4404EUR$4,750USD£3,684GBP
- Report
- August 2026
- 160 Pages
Global
From €3078EUR$3,320USD£2,575GBP
€3848EUR$4,150USD£3,218GBP
- Report
- January 2026
- 308 Pages
Global
From €2318EUR$2,500USD£1,939GBP
- Report
- May 2026
- 165 Pages
Global
From €3662EUR$3,950USD£3,063GBP
- Report
- May 2026
- 146 Pages
Global
From €3662EUR$3,950USD£3,063GBP
- Report
- July 2026
- 136 Pages
Global
From €4497EUR$4,850USD£3,761GBP
- Report
- October 2026
- 304 Pages
Global
From €6485EUR$6,995USD£5,425GBP
- Report
- October 2026
- 367 Pages
Global
From €3871EUR$4,175USD£3,238GBP
- Report
- October 2026
- 325 Pages
Global
From €3871EUR$4,175USD£3,238GBP
- Report
- October 2026
- 327 Pages
Global
From €3871EUR$4,175USD£3,238GBP
- Report
- October 2026
- 327 Pages
Global
From €3871EUR$4,175USD£3,238GBP
- Report
- October 2026
- 378 Pages
Global
From €3871EUR$4,175USD£3,238GBP
- Report
- October 2026
- 327 Pages
Global
From €3871EUR$4,175USD£3,238GBP
- Report
- July 2026
- 284 Pages
Global
From €3848EUR$4,150USD£3,218GBP

Pharmacogenomics is a field of genomics that studies the relationship between an individual's genetic makeup and their response to drugs. It is used to develop personalized medicine, which is tailored to an individual's genetic profile. This field of genomics has the potential to revolutionize the way drugs are developed and prescribed, as it can help to identify which drugs are most effective for a particular patient. It can also help to reduce the risk of adverse drug reactions, as well as reduce the cost of drug development.
Pharmacogenomics is a rapidly growing field, with many companies investing in research and development. Examples of companies in the market include 23andMe, Genomics England, and Illumina. Show Less Read more